Home  |  Contact

UniProtKB/Swiss-Prot P02533: Variant p.Met119Ile

Keratin, type I cytoskeletal 14
Gene: KRT14
Variant information

Variant position:  119
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Methionine (M) to Isoleucine (I) at position 119 (M119I, p.Met119Ile).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In WC-EBS at heterozygosity; more severe phenotype is associated with homozygosity.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  119
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  472
The length of the canonical sequence.

Location on the sequence:   GFGGGFAGGDGLLVGSEKVT  M QNLNDRLASYLDKVRALEEA
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GFGGGFAG--GDGLLVGSEKVTMQNLNDRLASYLDKVRALEEA

Mouse                         GLGGGLGGGIGDGLLVGSEKVTMQNLNDRLATYLDKVRALE

Rat                           GIGSGFGGGLGDGLLVGSEKVTMQNLNDRLATYLDKVRALE

Chicken                       GFGGGFGG--GDGILPAGEKETMQNLNDRLAAYLDKVRALE

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 472 Keratin, type I cytoskeletal 14
Domain 115 – 426 IF rod
Region 115 – 150 Coil 1A


Literature citations

Keratin 14 gene mutations in patients with epidermolysis bullosa simplex.
Chen H.; Bonifas J.M.; Matsumura K.; Ikeda S.; Leyden W.A.; Epstein E.H. Jr.;
J. Invest. Dermatol. 105:629-632(1995)
Cited for: VARIANTS WC-EBS ILE-119; ASP-274; ASN-377 AND CYS-388; VARIANTS DM-EBS ARG-120; CYS-125 AND SER-125;

Partial dominance of a keratin 14 mutation in epidermolysis bullosa simplex: increased severity of disease in a homozygote.
Hu Z.L.; Smith L.; Martins S.; Bonifas J.M.; Chen H.; Epstein E.H. Jr.;
J. Invest. Dermatol. 109:360-364(1997)
Cited for: VARIANT WC-EBS ILE-119;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.